About nine years ago, after being treated in New York for a few years for prostate cancer, William B. Finneran asked two friends to suggest a doctor who could render a second opinion.
His prostate-specific antigen numbers were high, and doctors in New York suggested surgery to remove his prostate, he said.
The friends with whom he spoke fellow Palm Beacher David Koch and financier Michael Milken, founder of the Prostate Cancer Foundation had been treated for the same condition by oncologist Dr. Christopher J. Logothetis of MD Anderson Cancer Center in Houston. They suggested he give Logothetis a call, Finneran said.
Logothetis used hormone therapy to put Finnerans prostate cancer in remission. Hes made countless trips to Houston for treatment at MD Anderson, part of the University of Texas.
The treatments have gone very well. Im still here, he said with a laugh at his North End home.
Clinical treatments
Finneran decided this year to reward MD Anderson for the care he continues to receive there.
He established the Finneran Family Prize, which grants $50,000 each year to an MD Anderson scientist for translational cancer research. Such work takes laboratory discoveries and converts them into clinical treatments for patients.
Finneran said he made the sizable investment because he appreciates MD Andersons core values, which, he said, are compassion and integrity. For 2014, US. News & World Report ranked MD Anderson No. 2 in the country for cancer care.
Right away you recognize it isnt one doctor making decisions, its a team there, Finneran said. Not only have they made a difference in my life, I think they are going to do it for millions of people. I started out as a patient, now Im a supporter of their effort to eradicate cancer.
Visit link:
Prostate cancer patient gives back to MD Anderson